Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy

Annales d'Endocrinologie

Volumn 73, Issue 1, 2012, Pages 37-42

  Tudorancea, Ancuta ^a   François, Patrick ^a   Trouillas, Jacqueline ^b   Cottier, Jean Philippe ^a   Girard, Jean Jacques ^a   Jan, Michel ^a   Gilbert Dussardier, Brigitte ^c   Richard, Stéphane ^d   Lecomte, Pierre ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANGIOGENESIS; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HEMANGIOBLASTOMA; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; LASER COAGULATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREOPERATIVE PERIOD; PROLACTINOMA; VASCULAR LESION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VON HIPPEL LINDAU DISEASE;

ADENOMA; ADOLESCENT; ANTINEOPLASTIC AGENTS; ERGOLINES; HUMAN GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PITUITARY NEOPLASMS; PROLACTIN; SOMATOSTATIN; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84857499967     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.12.001     Document Type: Article

References (19)

1. Lindau R.S., Graff J., Resche F. Von Hippel-Lindau disease. Lancet 2004, 363:1231-1234.
2. Lonser R.S., Glenn G.M., McClellan W., Chew E.Y., Libutti S.K., Linehan W.M., et al. Von Hippel-Lindau Disease. Lancet 2003, 361:2059-2067.
3. Mindermann T., Wilson C.B. Pituitary adenomas in childhood and adolescence. J Pediatr Endocrinol Metab 1995, 8:79-83.
4. Dollfus H., Massin P., Taupin P., Nemeth C., Amara S., Giraud S., et al. Ocular manifestations in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci 2002, 43:3067-3074.
5. Turner H.E., Harris A.L., Melmed S., Wass J.A. Angiogenesis in endocrine tumors. Endocr Rev 2003, 24:600-632.
6. Vidal S., Stefaneanu L., Kovacs K., Scheithauer B.W. Expression of von Hippel-Lindau protein (VHL-P) in non tumorous and adenomatous human pituitaries. Pituitary 1999, 1:227-232.
7. Turner H.E., Nagy Z.S., Gatter K.C., Esiri M.M., Harris A.L., Wass J.A.H. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 2000, 85:1159-1162.
8. Turner H.E., Nagy Z.S., Gatter K.C., Esiri M.M., Wass J.A.H., Harris A.L. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br J Cancer 2000, 82:1441-1445.
9. Peyre M., David P., Van Effenterre R., François P., Thys M., Emery E., et al. Disease and inherited predisposition to kidney cancer. Natural history of supratentorial hemangioblastomas in von Hippel-Lindau disease. Neurosurgery 2010, 67:577-587.
10. Lee S.H., Park B.J., Kim T.S., Lim Y.J. Long-term follow-up clinical courses of cerebellar hemangioblastoma in Von Hippel-Lindau disease: two case reports and a literature review. J Korean Neurosurg Soc 2010, 48:263-267.
11. Lonser R.R., Butman J.A., Kiringoda R., Song D., Oldfield E.H. Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 2009, 110:350-353.
12. Keil M.F., Stratakis C.A. Pituitary tumors in childhood: an update in their diagnosis, treatment and molecular genetics. Expert Rev Neurother 2008, 8:563-574.
13. Abe T., Tara L.A., Lüdecke D.K. Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. Neurosurgery 1999, 45:1-10.
14. Jimenez C., Cabanillas M.E., Santarpia L., Jonasch E., Kyle K.L., Lano E.A., et al. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metabol 2009, 94:386-391.
15. Kurosaki M., Saegert W., Abe T., Lüdecke D.K. Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment. Neurol Res 2008, 30:518-522.
16. Raverot G., Sturm N., de Fraipont F., Muller M., Salenave S., Caron P., et al. Temozolomide treatment of aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 2010, 95:4592-4599.
17. Schimke RN, Collins DL, Stolle CA. Von Hippel-Lindau syndrome. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. Gene reviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2000.(updated 2009 Dec 22).
18. Béroud C., Joly D., Gallou C., Staroz F., Orfanelli M.T., Junien C. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 1998, 26:256-258.
19. Nordstrom-O'Brien M., van der Luijt R.B., van Rooijen E., van der Ouweland A.M., Majoor-Krakauer D.F., Lolkema M.P., et al. Genetic analysis of von Hippel-Lindau disease. Human Mutat 2010, 31:521-537.